Results 121 to 130 of about 275,056 (297)

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Characteristics of Specialist‐Diagnosed Asthma‐COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR)

, 2020
Hyun Lee, Sang‐Heon Kim, Byung‐Keun Kim, Young‐Soo Lee, Hwa Young Lee, Ga‐Young Ban, Min‐Hye Kim, Joo‐Hee Kim, Jae‐Woo Kwon, So‐Young Park, Jae‐Woo Jung, So Young Park, Chan Sun Park, Chin Kook Rhee, Taehoon Lee, Jae‐Hyun Lee, So Ri Kim, Jong‐Sook Park, Heung‐Woo Park, Kwang Ha Yoo, Yeon‐Mok Oh, Young‐Il Koh, Byung‐Jae Lee, An‐Soo Jang, Sang‐Heon Cho, Hae‐Sim Park, Choon‐Sik Park, You Sook Cho, Ho Joo Yoon   +28 more
openalex   +2 more sources

Investigation of Lung Sounds Features for Detection of Bronchitis and COPD Using Machine Learning Methods

, 2021
Hanna Porieva, Kateryna Ivanko, C. I. Semkiv, Valentyn Vaityshyn   +3 more
openalex   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

Clinical Pharmacology &Therapeutics, EarlyView.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe, Tomoaki Hasegawa, Kazuhiro Kajiyama, Taihei Tanaka   +5 more
wiley   +1 more source

Some aspects of stable angina treatment: risk of complications assessment in a combined course with COPD

, 2014
В. К. Тащук, T. Amelina, A. S. Polianska, О. I. Hulaga   +3 more
openalex   +2 more sources

Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD [PDF]

, 2008
Mario Cazzola, Gian Luca Biscione, Franco Pasqua, Girolmina Crigna, Massimiliano Appodia, Vittorio Cardaci, Luigi Ferri   +6 more
openalex   +1 more source

Assessment of health status and its correlation with lung function in patients with COPD: a study from a tertiary care centre in north India

, 2023
Ankur Gupta, Kranti Garg, Vishal Chopra, Surinder Singh   +3 more
openalex   +2 more sources

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial

Clinical Pharmacology &Therapeutics, EarlyView.
Verekitug, a novel, high‐affinity, fully human monoclonal antibody targeting thymic stromal lymphopoietin receptor (TSLPR), is in development as a potential treatment for severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD).
Dave Singh, Chaim M. Brickman, Peter Lloyd, Ashish Kalra, Subhabrata Biswas, Arkadeep Sinha, Alex Mulvanny, Sumathi Sivapalasingam, Oren M. Becker, Aaron Deykin   +9 more
wiley   +1 more source

The clinical relevance of the emphysema-hyperinflated phenotype in COPD [PDF]

, 2015
Bruno‐Pierre Dubé, Antoine Guerder, Capucine Morélot-Panzini, Pierantonio Laveneziana   +3 more
openalex   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source